Opportunity Information: Apply for RFA DA 15 007
Apply for RFA DA 15 007
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Apr 4, 2014 and posted on Apr 4, 2014.
- Applicants must submit their applications by Nov 14, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments State governments Public housing authorities/Indian housing authorities Small businesses Independent school districts Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2), Funding Opportunity Number RFA-DA-15-007, is a National Institutes of Health (NIH) grant opportunity administered through the National Institute on Drug Abuse (NIDA) that is designed to invest in the next generation of scientific leaders. "Avenir" means "future" in French, and the program is intentionally structured to support early stage investigators who are proposing bold, highly innovative projects. A key idea behind the program is that promising researchers early in their careers often have transformative ideas but may not yet have the extensive preliminary data typically expected for a standard R01 award. This mechanism aims to bridge that gap by backing high-impact, high-potential work on the strength of the concept and the investigator's promise.
This specific Avenir program focuses on research at the intersection of substance use and HIV/AIDS. NIDA’s intent is to support creative, forward-looking studies that address the unique needs of people who use substances and who are living with HIV or are at risk of acquiring HIV. The announcement emphasizes research that could change the trajectory of prevention and care for these populations, including work that leads to better preventive interventions, improved therapeutic approaches, stronger long-term retention in HIV care, and progress toward the ultimate goal of HIV eradication. In practical terms, the opportunity targets projects that tackle real-world barriers and opportunities where substance use and HIV outcomes overlap, whether those involve behavioral, clinical, systems-level, or intervention-focused approaches.
Administratively, this is a discretionary grant program with a DP2 funding instrument type. It falls under the health and education activity category and is listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The opportunity did not require cost sharing or matching, reducing the financial burden on applicants and making it more accessible to investigators and institutions that may not have substantial discretionary resources.
The funding details indicate an estimated total program funding level of $1,500,000, with an award ceiling of $300,000. The opportunity was originally posted on April 4, 2014, with the closing date listed as November 14, 2016, and an archive date of December 15, 2016, meaning it was a time-limited solicitation that is no longer open under that specific announcement.
Eligibility was broad across U.S.-based organizational types, reflecting NIH’s interest in attracting strong proposals from many corners of the research ecosystem. Eligible applicants included public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses, though small businesses were also listed as eligible), and a wide range of government entities such as state, county, city or township governments, special district governments, independent school districts, and public housing authorities. Tribal eligibility was also included, covering federally recognized Native American tribal governments as well as other tribal organizations. The announcement further clarified that additional eligible applicants included minority-serving institutions (such as HBCUs, Hispanic-serving institutions, AANAPISIs, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. At the same time, the opportunity explicitly excluded non-U.S. (foreign) institutions and foreign components of U.S. organizations, and it did not allow foreign components as defined by the NIH Grants Policy Statement.
For applicants or interested parties seeking the full official text, NIH provided an online link to the complete announcement and offered technical assistance contacts through the NIH Office of Extramural Research (OER) Webmaster for access or linking issues.
FAQs: Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) - RFA-DA-15-007
What is this grant opportunity?
This opportunity is the Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2), Funding Opportunity Number RFA-DA-15-007. It is a National Institutes of Health (NIH) grant opportunity administered through the National Institute on Drug Abuse (NIDA).
What does "Avenir" mean, and what is the program trying to do?
"Avenir" means "future" in French. The program is intended to invest in the next generation of scientific leaders by supporting early stage investigators with bold, highly innovative research ideas.
Who is the program designed to support?
The program is intentionally structured to support early stage investigators, particularly those proposing transformative, high-potential projects that may not yet have the extensive preliminary data typically expected for a standard R01 award.
What is the main scientific focus of this Avenir program?
This specific Avenir program focuses on research at the intersection of substance use and HIV/AIDS, aiming to support creative and forward-looking studies that address the needs of people who use substances and who are living with HIV or are at risk of acquiring HIV.
What kinds of outcomes or impacts is NIDA looking for?
The announcement emphasizes research that could change the trajectory of HIV prevention and care for populations affected by substance use. Examples of emphasized goals include better preventive interventions, improved therapeutic approaches, stronger long-term retention in HIV care, and progress toward the ultimate goal of HIV eradication.
What types of research approaches are relevant under this announcement?
The opportunity targets projects that address real-world barriers and opportunities where substance use and HIV outcomes overlap. The description notes that projects may involve behavioral, clinical, systems-level, or intervention-focused approaches, as long as they align with the substance use and HIV/AIDS intersection described.
Which agency and institute administer the program?
The opportunity is within NIH and is administered through NIDA (the National Institute on Drug Abuse).
What is the funding instrument type?
The funding instrument type is DP2.
Is this a discretionary grant program?
Yes. The opportunity is described as a discretionary grant program.
What is the activity category for this opportunity?
It falls under the health and education activity category.
What CFDA number is associated with this opportunity?
The opportunity is listed under CFDA 93.279, Drug Abuse and Addiction Research Programs.
How much total funding was estimated for the program?
The estimated total program funding level is $1,500,000.
What is the award ceiling for an individual award?
The award ceiling is $300,000.
Was cost sharing or matching required?
No. The opportunity did not require cost sharing or matching.
When was the opportunity posted?
The opportunity was originally posted on April 4, 2014.
What was the closing date for applications?
The closing date listed was November 14, 2016.
Is this funding opportunity still open?
No. The announcement was time-limited and is no longer open under that specific solicitation. It also lists an archive date of December 15, 2016.
What types of U.S. organizations were eligible to apply?
Eligibility was broad across U.S.-based organizational types. Eligible applicants included public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses, though small businesses were also listed as eligible), and a wide range of government entities.
Which government entities were included as eligible applicants?
The eligible government entities listed included state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities.
Were tribal entities eligible?
Yes. Tribal eligibility included federally recognized Native American tribal governments as well as other tribal organizations.
Were minority-serving institutions specifically mentioned as eligible?
Yes. The announcement specifically referenced minority-serving institutions, including HBCUs, Hispanic-serving institutions, AANAPISIs, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities.
Were faith-based or community-based organizations eligible?
Yes. The announcement stated that faith-based or community-based organizations were included among eligible applicants.
Were U.S. territories or possessions included?
Yes. U.S. territories or possessions were included among eligible applicants.
Could federal agencies apply?
Yes. The eligibility list included eligible federal agencies.
Are non-U.S. (foreign) institutions eligible?
No. The opportunity explicitly excluded non-U.S. (foreign) institutions.
Are foreign components of U.S. organizations allowed?
No. The opportunity did not allow foreign components as defined by the NIH Grants Policy Statement, and it explicitly excluded foreign components of U.S. organizations.
Where can someone find the official full announcement text?
NIH provided an online link to the complete announcement. For access or linking issues, technical assistance contacts were offered through the NIH Office of Extramural Research (OER) Webmaster.
Who should be contacted for technical problems accessing the announcement?
The opportunity noted technical assistance contacts through the NIH Office of Extramural Research (OER) Webmaster for access or linking issues.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: National Center for Building Community Trust and Justice Improving the Justice System by Enhancing Procedural Justice, Reducing Bias, and Supporting Racial Reconciliation
Previous opportunity: DOI Hurricane Sandy Project #NE033 Parkers River Yarmouth MA Replace Bridge and Restore Tidal Flow
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 15 007
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 15 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Healthy Habits Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21) Apply for PA 14 176 Funding Number: PA 14 176 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Healthy Habits Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01) Apply for PA 14 177 Funding Number: PA 14 177 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient Provider Communication, Adherence to Treatment and Self Management (R01) Apply for PA 14 180 Funding Number: PA 14 180 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient Provider Communication, Adherence to Treatment and Self Management (R21) Apply for PA 14 181 Funding Number: PA 14 181 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01) Apply for PAR 14 184 Funding Number: PAR 14 184 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revisions to Add Biomedical Big Data Training to Active NLM Institutional Training Grants in Biomedical Informatics (T15) Apply for RFA HG 14 006 Funding Number: RFA HG 14 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Core Center of Excellence Grant Program (P30) Apply for PAR 14 186 Funding Number: PAR 14 186 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Lasker Clinical Research Scholars Program (Si2) Apply for RFA OD 14 004 Funding Number: RFA OD 14 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Information Resource Grants to Reduce Health Disparities (G08) Apply for RFA LM 14 001 Funding Number: RFA LM 14 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Wild Horse and Burro Contraception Apply for L14AS00048 Funding Number: L14AS00048 Agency: Bureau of Land Management Category: Education Health Funding Amount: $500,000 |
| Chronic Wounds Advancing the Science from Prevention to Healing (R01) Apply for RFA NR 15 001 Funding Number: RFA NR 15 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Long Term Retention in Care for U.S. Substance Using Populations (R34) Apply for PA 14 222 Funding Number: PA 14 222 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Long Term Retention in Care for U.S. Substance Using Populations (R21) Apply for PA 14 223 Funding Number: PA 14 223 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Long Term Retention in Care for U.S. Substance Using Populations (R01) Apply for PA 14 224 Funding Number: PA 14 224 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain (R01) Apply for PAR 14 225 Funding Number: PAR 14 225 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33) Apply for PAR 14 230 Funding Number: PAR 14 230 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R33) Apply for PAR 14 231 Funding Number: PAR 14 231 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 14 234 Funding Number: PAR 14 234 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Research Projects to Enhance Applicability of Mouse Models for Translational Research (Collaborative R01) Apply for PAR 14 240 Funding Number: PAR 14 240 Agency: National Institutes of Health Category: Education Health Funding Amount: $450,000 |
| Research Projects to Enhance Applicability of Mouse Models for Translational Research (R01) Apply for PAR 14 241 Funding Number: PAR 14 241 Agency: National Institutes of Health Category: Education Health Funding Amount: $450,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 15 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.